ANA M.
MARQUEZ ORTIZ
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (12)
2021
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
2017
-
A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294
2016
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
-
Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome
Pharmacogenetics and Genomics, Vol. 24, Núm. 1, pp. 1-5
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745
-
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab
Human Immunology, Vol. 75, Núm. 1, pp. 71-75
2013
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
2006
-
No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population
Tissue Antigens, Vol. 68, Núm. 6, pp. 489-492